CVRx (CVRX) said late Monday that it expects to report roughly $12.3 million in Q1 revenue compared with $10.8 million during the year-ago period.
Analysts polled by FactSet, on average, expected $14.7 million.
The medical device company also said it finished the quarter ended March 31 with around $102.7 million in cash and cash equivalents, compared with $105.9 million at the end of December.
CVRx is scheduled to report its full Q1 financial results on May 8 after market close.
CVRx shares were sinking over 7% during after-hours session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.